Skip to main navigation Skip to search Skip to main content

Omalizumab = Modest Benefit, High Cost for Children With Allergic Asthma

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Pages (from-to)784-785
Number of pages2
JournalJournal of the National Medical Association
Volume103
Issue number8
DOIs
StatePublished - Jul 2011

ASJC Scopus Subject Areas

  • General Medicine

Cite this